Aclaris Therapeutics
ACRS
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.27 | -0.10 | 0.17 | 62.96% |
| Revenue | 5.85M | 9.21M | 3.36M | 57.45% |
WhatIF - Earnings
EPS Beat Expectations by $0.17
Aclaris Therapeutics (ACRS:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything